NO972771L - Ny reseptor - Google Patents
Ny reseptorInfo
- Publication number
- NO972771L NO972771L NO972771A NO972771A NO972771L NO 972771 L NO972771 L NO 972771L NO 972771 A NO972771 A NO 972771A NO 972771 A NO972771 A NO 972771A NO 972771 L NO972771 L NO 972771L
- Authority
- NO
- Norway
- Prior art keywords
- binds
- compound
- tissue
- brain tissue
- rat
- Prior art date
Links
- 210000005013 brain tissue Anatomy 0.000 abstract 4
- 229940126062 Compound A Drugs 0.000 abstract 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 210000004129 prosencephalon Anatomy 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9425502.3A GB9425502D0 (en) | 1994-12-17 | 1994-12-17 | Novel receptor |
PCT/EP1995/004998 WO1996018650A1 (en) | 1994-12-17 | 1995-12-11 | Novel receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
NO972771D0 NO972771D0 (no) | 1997-06-16 |
NO972771L true NO972771L (no) | 1997-08-15 |
Family
ID=10766105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972771A NO972771L (no) | 1994-12-17 | 1997-06-16 | Ny reseptor |
Country Status (15)
Country | Link |
---|---|
US (1) | US5985334A (cs) |
EP (1) | EP0807122A1 (cs) |
JP (1) | JPH10511083A (cs) |
CN (1) | CN1175262A (cs) |
AU (1) | AU710150B2 (cs) |
BR (1) | BR9510060A (cs) |
CA (1) | CA2207921A1 (cs) |
CZ (1) | CZ187697A3 (cs) |
FI (1) | FI972558A0 (cs) |
GB (1) | GB9425502D0 (cs) |
HU (1) | HUT77077A (cs) |
NO (1) | NO972771L (cs) |
NZ (1) | NZ298059A (cs) |
PL (1) | PL320747A1 (cs) |
WO (1) | WO1996018650A1 (cs) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245893B1 (en) * | 1994-12-17 | 2001-06-12 | Smithkline Beecham P.L.C. | Receptor that binds anti-convulsant compounds |
WO2021179064A1 (en) * | 2020-03-10 | 2021-09-16 | Epic Ventures Inc. | Light-activated pathogen-killing molecules and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
GB9225860D0 (en) * | 1992-12-11 | 1993-02-03 | Smithkline Beecham Plc | Novel treatment |
WO1995006117A1 (en) * | 1993-08-20 | 1995-03-02 | Smithkline Beecham Plc | Human 5-ht2 receptor |
-
1994
- 1994-12-17 GB GBGB9425502.3A patent/GB9425502D0/en active Pending
-
1995
- 1995-12-11 JP JP8518283A patent/JPH10511083A/ja active Pending
- 1995-12-11 AU AU43458/96A patent/AU710150B2/en not_active Ceased
- 1995-12-11 CA CA002207921A patent/CA2207921A1/en not_active Abandoned
- 1995-12-11 CZ CZ971876A patent/CZ187697A3/cs unknown
- 1995-12-11 CN CN95197647A patent/CN1175262A/zh active Pending
- 1995-12-11 HU HU9702146A patent/HUT77077A/hu unknown
- 1995-12-11 US US08/849,860 patent/US5985334A/en not_active Expired - Fee Related
- 1995-12-11 NZ NZ298059A patent/NZ298059A/xx unknown
- 1995-12-11 BR BR9510060A patent/BR9510060A/pt not_active Application Discontinuation
- 1995-12-11 PL PL95320747A patent/PL320747A1/xx unknown
- 1995-12-11 EP EP95942175A patent/EP0807122A1/en not_active Withdrawn
- 1995-12-11 WO PCT/EP1995/004998 patent/WO1996018650A1/en not_active Application Discontinuation
-
1997
- 1997-06-16 NO NO972771A patent/NO972771L/no not_active Application Discontinuation
- 1997-06-16 FI FI972558A patent/FI972558A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
GB9425502D0 (en) | 1995-02-15 |
EP0807122A1 (en) | 1997-11-19 |
JPH10511083A (ja) | 1998-10-27 |
CA2207921A1 (en) | 1996-06-20 |
FI972558A (fi) | 1997-06-16 |
NO972771D0 (no) | 1997-06-16 |
PL320747A1 (en) | 1997-10-27 |
AU4345896A (en) | 1996-07-03 |
CN1175262A (zh) | 1998-03-04 |
AU710150B2 (en) | 1999-09-16 |
CZ187697A3 (en) | 1997-10-15 |
BR9510060A (pt) | 1998-06-02 |
HUT77077A (hu) | 1998-03-02 |
NZ298059A (en) | 2000-03-27 |
US5985334A (en) | 1999-11-16 |
FI972558A0 (fi) | 1997-06-16 |
WO1996018650A1 (en) | 1996-06-20 |
MX9704560A (es) | 1997-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300808I1 (cs) | ||
CA2278151A1 (en) | Heregulin variants | |
DZ3482A1 (fr) | Secretagogues de l'hormone de croissance | |
EP1017713A4 (en) | CYCLIC AGONISTS AND ANTAGONISTS OF THE C5A RECEPTORS AND G-PROTEIN COUPLED RECEPTORS | |
RS80704A (en) | ANTI- av?6.ANTIBODIES | |
DK1765860T3 (da) | Ny-ESO-T.cellereceptor med höj affinitet | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
ATE165395T1 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
ES2196072T3 (es) | Empleo de compuestos heterociclicos como ligandos de dopamina-d3. | |
DE69942753D1 (de) | Peptidantagonist von Zonulin und dessen Verwendung | |
ES2194918T3 (es) | Compuestos de tiazol y tiadiazol como ligando receptor de dopamina d3. | |
TR200102338T2 (tr) | Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar. | |
DK0772603T3 (da) | Substituerede pyrimidinforbindelser og deres anvendelse | |
DK1129186T3 (da) | Et faktor VIII-polypeptid med faktor VIII:C-aktivitet | |
NZ301916A (en) | Monoclonal antibodies to il-5 for use as antagonists to il-5 related disorders | |
DK0754301T3 (da) | Fremstilling og stabilisering af cellesuspensioner | |
BR0116686A (pt) | Anticorpos anti-cd28 silenciados e uso dos mesmos | |
CO5460266A1 (es) | Novedosos analogos de la somatostatina | |
EA200000086A1 (ru) | Алатрофлоксациновые парентеральные составы | |
NO972771L (no) | Ny reseptor | |
ATE408631T1 (de) | Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion | |
DK0811058T3 (da) | Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder | |
ES2195033T3 (es) | Iso-indolonas condensadas utilizadas como inhibidores de proteina quinasa c. | |
EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
ATE317021T1 (de) | Antisense modulierung von lfa-3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |